Equities

electroCore, Inc.

  • Add to watchlist
  • Add to portfolio
  • Add an alert

electroCore, Inc.

Actions
Health CareMedical Equipment and Services
  • Price (USD)5.43
  • Today's Change-0.16 / -2.86%
  • Shares traded41.41k
  • 1 Year change-68.38%
  • Beta0.5495
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

  • Revenue in USD (TTM)29.84m
  • Net income in USD-14.16m
  • Incorporated2005
  • Employees73.00
  • Location
    electroCore, Inc.200 FORGE WAY, SUITE 205ROCKAWAY 07866United StatesUSA
  • Phone+1 (973) 290-0097
  • Fax+1 (973) 290-9171
  • Websitehttps://www.electrocore.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ekso Bionics Holdings Inc14.75m-10.66m33.49m61.00--2.67--2.27-5.70-5.707.253.690.57991.362.27241,786.90-41.02-41.01-60.62-52.9053.4852.89-70.74-97.041.09--0.3055---1.945.1925.45---9.22--
RenovoRx Inc928.00k-11.11m34.21m10.00--4.23--36.86-0.4375-0.43750.03120.22040.0874----92,800.00-104.58-121.57-126.33-166.5067.78---1,196.66-90,830.235.68--0.00------13.86------
TELA Bio Inc77.06m-39.00m34.54m209.00--20.45--0.4483-0.8863-0.88631.750.03861.342.016.85368,684.20-68.06-51.29-96.57-60.7067.2366.26-50.61-88.022.62-7.250.9638--18.5635.0218.91---18.18--
Modular Medical Inc0.00-24.22m35.22m54.00--3.16-----0.5081-0.50810.000.14340.00----0.00-222.79-171.42-294.38-207.14------------0.00-------7.75--57.07--
Vivos Inc48.63k-3.01m35.42m10.00--16.25--728.32-0.0068-0.00680.00010.00480.0275--10.03---170.12-166.49-178.25-242.01-127.332.81-6,191.01-11,105.9819.81--0.00--43.5924.13-0.5424------
Precision Optics Corporation Inc21.58m-6.11m36.75m90.00--3.36--1.70-0.8505-0.85053.011.421.095.005.90239,722.70-30.82-13.63-45.79-19.5114.9929.56-28.30-11.580.785-28.850.1375---0.068513.98-95.85--7.81--
Icecure Medical Ltd2.98m-15.29m39.31m64.00--4.22--13.21-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Cytosorbents Corp34.35m-10.59m40.28m149.00--4.47--1.17-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
Precipio Inc22.80m-1.25m40.98m54.00--2.97169.341.80-0.835-0.83514.637.881.2018.2615.31422,222.20-6.58-38.01-8.60-46.9844.8233.80-5.50-71.341.10-24.190.074--21.9542.7426.70--32.31--
Neuroone Medical Technologies Corp12.10m-3.61m41.01m18.00--5.75--3.39-0.0784-0.07840.30120.14141.501.6316.79672,094.40-44.63-113.64-61.95-152.0867.3060.94-29.80-223.443.47--0.1519--250.3544.4170.73---7.76--
electroCore, Inc.29.84m-14.16m43.42m73.00------1.46-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Heartbeam Inc0.00-20.62m45.81m16.00--112.50-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
Spectral AI Inc23.17m-16.37m47.57m78.00------2.05-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Nutriband Inc2.28m-34.59m50.04m13.00--6.62--21.96-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Sharps Technology Inc2.51m-104.37m51.03m5.00--0.1122--20.32-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Neuraxis Inc3.36m-8.37m52.31m21.00--21.28--15.56-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
Data as of Feb 13 2026. Currency figures normalised to electroCore, Inc.'s reporting currency: US Dollar USD

Institutional shareholders

10.56%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2025202.64k2.53%
MAZ Capital Advisors LLCas of 13 May 2025130.52k1.63%
Tejara Capital Ltd.as of 31 Dec 2025100.38k1.26%
International Assets Investment Management LLCas of 31 Dec 202588.72k1.11%
Geode Capital Management LLCas of 31 Dec 202570.20k0.88%
DRW Securities LLCas of 31 Dec 202558.77k0.74%
Renaissance Technologies LLCas of 31 Dec 202554.49k0.68%
Jaffe Tilchin Investment Partners LLCas of 31 Dec 202552.36k0.66%
Wealthspire Advisors LLCas of 31 Dec 202547.50k0.59%
Vanguard Fiduciary Trust Co.as of 31 Dec 202538.53k0.48%
More ▼
Data from 01 Oct 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.